Stress cardiomyopathy misinterpreted as ST-segment elevation myocardial infarction in a patient with aneurysmal subarachnoid hemorrhage: a case report

1. WARTENBERG KE, MAYER SA. Medical Complications After Subarachnoid Hemorrhage. Neurosurg Clin N Am. 2010; 21(2):325–38.10.1016/j.nec.2009.10.012Search in Google Scholar

2. ARONOW WS. Neurogenic stress cardiomyopathy associated with subarachnoid hemorrhage. Future Cardiol. 2015; 11(1):77–87.10.2217/fca.14.73Search in Google Scholar

3. HUANG CC, HUANG CH, KUO HY, CHAN CM, CHEN JH, CHEN WL. The 12-lead electrocardiogram in patients with subarachnoid hemorrhage: Early risk prognostication. Am J Emerg Med. 2012; 30(5):732–6.10.1016/j.ajem.2011.05.003Search in Google Scholar

4. MANSELLA G, JEGER R, BINGISSER R, NICKEL C. The Neurocardiogenic Spectrum in Subarachnoid Hemorrhage: A Case Report and Review of the Literature. Clin Pract Cases Emerg Med. 2017; 1(1):16–21.10.5811/cpcem.2016.11.32582Search in Google Scholar

5. BISO S, WONGRAKPANICH S, AGRAWAL A, YADLAPATI S, KISHLYANSKY M, FIGUEREDO V. A Review of Neurogenic Stunned Myocardium. Cardiovasc Psychiatry Neurol. 2017; 2017.10.1155/2017/5842182Search in Google Scholar

6. BRIGNOLE M, MOYA A, DE LANGE FJ, DEHARO JC, ELLIOTT PM, FANCIULLI A, et al. 2018 ESC Guidelines for the diagnosis and management of syncope. Eur Heart J. 2018; 39(21):1883–948.10.1093/eurheartj/ehy037Search in Google Scholar

7. SUWATCHARANGKOON S, MEYERS E, FALO C, SCHMIDT JM, AGARWAL S, CLAASSEN J, et al. Loss of consciousness at onset of subarachnoid hemorrhage as an important marker of early brain injury. JAMA Neurol. 2016; 73(1):28–35.10.1001/jamaneurol.2015.3188Search in Google Scholar

8. CREMERS CHP, VAN DER BILT IAC, VAN DER SCHAAF IC, VERGOUWEN MDI, DANKBAAR JW, CRAMER MJ, et al. Relationship Between Cardiac Dysfunction and Cerebral Perfusion in Patients with Aneurysmal Subarachnoid Hemorrhage. Neurocrit Care. 2016; 24(2):202–6.10.1007/s12028-015-0188-8Search in Google Scholar

9. KERRO A, WOODS T, CHANG JJ. Neurogenic stunned myocardium in subarachnoid hemorrhage. J Crit Care. 2017; 38:27–34.10.1016/j.jcrc.2016.10.010Search in Google Scholar

10. GHADRI JR, WITTSTEIN IS, PRASAD A, SHARKEY S, DOTE K, AKASHI YJ, et al. International Expert Consensus Document on Takotsubo Syndrome (Part I): Clinical Characteristics, Diagnostic Criteria, and Pathophysiology. Eur Heart J. 2018; 39(22):2032–46.10.1093/eurheartj/ehy076Search in Google Scholar

11. KRISHNAMOORTHY V, BURKHARD MACKENSEN G, GIBBONS EF, VAVILALA MS. Cardiac dysfunction after neurologic injury what do we know and where are we going? Chest. 2016; 149(5):1325–31.10.1016/j.chest.2015.12.014Search in Google Scholar

12. TAMIS-HOLLAND JE, JNEID H, REYNOLDS HR, AGEWALL S, BRILAKIS ES, BROWN TM, et al. Contemporary Diagnosis and Management of Patients With Myocardial Infarction in the Absence of Obstructive Coronary Artery Disease: A Scientific Statement From the American Heart Association. Circulation. 2019; 139(18):E891–908.10.1161/CIR.0000000000000670Search in Google Scholar

13. KENIGSBERG BB, BARNETT CF, MAI JC, CHANG JJ. Neurogenic Stunned Myocardium in Severe Neurological Injury. Curr Neurol Neurosci Rep. 2019; 19(11).10.1007/s11910-019-0999-7Search in Google Scholar

14. ANCONA F, BERTOLDI LF, RUGGIERI F, CERRI M, MAGNONI M, BERETTA L, et al. Takotsubo cardiomyopathy and neurogenic stunned myocardium: Similar albeit different. Eur Heart J. 2016; 37(37):2830–2.10.1093/eurheartj/ehw035Search in Google Scholar

15. GUGLIN M, NOVOTOROVA I. Neurogenic Stunned Myocardium and Takotsubo Cardiomyopathy Are the Same Syndrome: A Pooled Analysis. Congest Hear Fail. 2011; 17(3):127–32.10.1111/j.1751-7133.2011.00210.xSearch in Google Scholar

16. WYBRANIEC M, MIZIA-STEC K, KRZYCH Ł. Neurocardiogenic injury in subarachnoid hemorrhage: A wide spectrum of catecholamin-mediated brain-heart interactions. Cardiol J. 2014; 21(3):220–8.10.5603/CJ.a2014.0019Search in Google Scholar

17. MEDINA DE CHAZAL H, DEL BUONO MG, KEYSER-MARCUS L, MA L, MOELLER FG, BERROCAL D, et al. Stress Cardiomyopathy Diagnosis and Treatment: JACC State-of-the-Art Review. J Am Coll Cardiol. 2018; 72(16):1955–71.10.1016/j.jacc.2018.07.072Search in Google Scholar

18. BULSARA KR, MCGIRT MJ, LIAO L, VILLAVICENCIO AT, BOREL C, ALEXANDER MJ, et al. Use of the peak troponin value to differentiate myocardial infarction from reversible neurogenic left ventricular dysfunction associated with aneurysmal subarachnoid hemorrhage. J Neurosurg. 2003; 98(3):524–8.10.3171/jns.2003.98.3.0524Search in Google Scholar

19. TEMPLIN C, GHADRI JR, DIEKMANN J, NAPP LC, BATAIOSU DR, JAGUSZEWSKI M, et al. Clinical features and outcomes of takotsubo (stress) cardiomyopathy. N Engl J Med. 2015; 373(10):929–38.10.1056/NEJMoa1406761Search in Google Scholar

20. GHADRI JR, CAMMANN VL, JURISIC S, SEIFERT B, NAPP LC, DIEKMANN J, et al. A novel clinical score (InterTAK Diagnostic Score) to differentiate takotsubo syndrome from acute coronary syndrome: results from the International Takotsubo Registry. Eur J Heart Fail. 2017; 19(8):1036–42.10.1002/ejhf.683Search in Google Scholar

21. KWOK CS, KONTOPANTELIS E, MYINT PK, ZAMAN A, BERRY C, KEAVNEY B, et al. Stroke following percutaneous coronary intervention: Type-specific incidence, outcomes and determinants seen by the British Cardiovascular Intervention Society 2007-12. Eur Heart J. 2015; 36(25):1618–28.10.1093/eurheartj/ehv113Search in Google Scholar

22. POTTEGÅRD A, RODRÍGUEZ LAG, POULSEN FR, HALLAS J, GAIST D. Antithrombotic drugs and subarachnoid haemorrhage risk: A nationwide case-control study in Denmark. Thromb Haemost. 2015; 114(5):1064–75.10.1160/TH15-04-0316Search in Google Scholar